2020
DOI: 10.1016/j.bcp.2020.114080
|View full text |Cite
|
Sign up to set email alerts
|

Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target NaV1.7

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 51 publications
0
7
0
Order By: Relevance
“…As part of our ongoing attempts to develop new pharmacological probes and therapeutic leads for human Na V channels, , we devised and tested in this study a bivalent linker design with a focus on Na V 1.4 and Na V 1.7 due to their (patho)­physiological relevance and experimentally determined structures. Our strategy was to covalently link a pore blocker toxin with a gating modifier toxin using variable-length polyethylene glycol (PEG) linkers to simultaneously target two binding sites of the channel, thereby potentially enhancing binding kinetics, potency, and subtype selectivity (Figure B,C).…”
Section: Introductionmentioning
confidence: 99%
“…As part of our ongoing attempts to develop new pharmacological probes and therapeutic leads for human Na V channels, , we devised and tested in this study a bivalent linker design with a focus on Na V 1.4 and Na V 1.7 due to their (patho)­physiological relevance and experimentally determined structures. Our strategy was to covalently link a pore blocker toxin with a gating modifier toxin using variable-length polyethylene glycol (PEG) linkers to simultaneously target two binding sites of the channel, thereby potentially enhancing binding kinetics, potency, and subtype selectivity (Figure B,C).…”
Section: Introductionmentioning
confidence: 99%
“…This suggests that this pH-dependence could potentially be exploited in the design of peptides as a “molecular switch” for use in the gastrointestinal tract, , lysosomes, secretory granules, and pH-altering states such as cancer, inflammation, , ischemia, and others . Peptides containing acidic residues that are protonated in acidic environments to promote membrane insertion have been studied for cancer and inflammation, , and other pH-sensitive peptides have been studied for various applications. …”
Section: Discussionmentioning
confidence: 99%
“…The two peptides (34 residues) β/μ-TRTX-Pe1a and β/μ-TRTX-Pe1b from the arboreal tarantula Phormingochilus everetti are Nav1.7 inhibitors. The recombinant Pe1b peptide shows potent and relative selective inhibition (IC 50 167nM) on Nav1.7 compared to other Nav isoforms such as Nav1.6, Nav1.5 and Nav1.2 [ 199 ].…”
Section: Spider Toxins Interacting With Pain-related Ion Channelsmentioning
confidence: 99%
“…ProTx analogues were designed to improve selectivity for Nav1.7 based on peptide pharmacophore and channel interaction [ 199 ]. Several mutants, with modified C terminus (ProTx-I-NH2 and ProTx-II-NHCH3), have increased activity on both Nav1.2 and Nav1.7 and a decreased activity on Nav1.5 and Nav1.6 [ 240 ].…”
Section: Spider Toxins Interacting With Pain-related Ion Channelsmentioning
confidence: 99%